Email
25 Jun 2012

ABPI hits out at MHRA negativity on European anti-counterfeiting plans

Supply chain The MHRA position on European plans to tighten up the supply chain will not sufficiently protect patients, ABPI chief executive Stephen...
Forgotten your password?
The page you are looking for is only available to logged in members of Chemist+Druggist.
Not a member yet?
Register now
If you are not a registered user, then please sign up here. Registering is free and takes just seconds. It gives you access to up-to-the minute news alerts and analysis, all our top bloggers.
If you experience any difficulties logging in or registering, or have any other questions, please contact Chemist+Druggist at haveyoursay@chemistanddruggist.co.uk
Comment on this article
You are not currently logged in. Login or register
Your Comments
Adrian Busuttil, Work for a pharmaceutical company
Posted on 25 June 2012.
I spent a number of years working as a community pharmacist and now I'm working as an RP. So I can speak from both sides of the coin from a Maltese perspective. In Malta we do not have a problme with counterfeits in the legal supply chain. But I think the hassle that these measures would bring for all stakeholders outweigh the advantages of ensuring counterfeit-free supply. So I agree with the MHRA and BAPW that regulation should be kept at a minimum as much as possible.
Top
Peter McAuley, Community pharmacist
Posted on 26 June 2012.
My comment is 'why should we need to scan every pack?'.
I buy everything from either a main line wholesaler or 2 reputable second line wholesalers.
Surely it is their responsibility to know where they are buying from and their QP to certify that every pack is not counterfeit.
Perhaps they should sign for this on every delivery to us. Put the onus back where it should be, with the supplier
Top

Please note You must be a registered user of Chemist+Druggist and logged in to add comments. Opinions expressed here are those of the writers and do not necessarily reflect those of Chemist+Druggist. Comments are considered in the public domain and may be used in future Chemist+Druggist coverage. We accept no responsibility, legal or otherwise, for the accuracy or the content of member comments. However, any comments deemed to be libellous will be removed

Job of the week

Commercial Services Manager

Runcorn, Cheshire
£competitive

Follow C+D Jobs on

  
Should pharmacists be involved in the MMR catch-up programme?